The sponsor requested an early termination of the study following insufficient engagement of subjects beyond 12 months of follow-up (initial follow-up was 18 months).

The study aim is to Assess the Effect of an IR Reflexotherapy on Overweight and Class I Obese People.

Inclusion Criteria:

• BMI between 27 and 35 kg/m2 (included),
• Aged 30 to 60 years old (included),
• Stable weight: no variation of 3 kg in the las 3 months,
• Signed the consent form,
• Able to follow the study,
• Health insured.

Exclusion Criteria:

• History of coronary disease (in the last 6 months),
• Progressive illness at the time of the study (cancer, neurodegenerative disease...),
• Diabetics (treated or not),
• Fasting blood total cholesterol equal or over 2.5 g/L (treated or not),
• Fasting blood triglycerides equal or over 2.0 g/L (treated or not),
• Fasting blood glucose equal or over 1.26 g/L,
• Peripheral neuropathy (polyneuritis, diabetic neuropathy) or central neuropathy (hemiplegia),
• Infectious cutaneous condition or allergies (to the contact point of the device),
• History of stroke,
• Severe heart disease,
• Epilepsy,
• Reduced motility,
• Diagnosed eating disorder,
• Followed a diet in the last 90 days in order to lose weight,
• Took weight loss assistance drug (Orlistat) in the last month or is likely to take one during the study,
• Psychiatric disorder incompatible with the study,
• Mental illness,
• Neurological disorder,
• Chronic somatic disease,
• Addiction or nicotine withdrawal,
• Under psychoactive drug ,
• Alcool consumption over 3 glasses a day,
• Pregnant or breastfeeding women,
• Women that are likely to get pregnant during the study,
• Is unable to understand or follow the protocol
• Is deprived of liberty
• Is under judicial protection